John I. Mackowiak

1.2k total citations
48 papers, 937 citations indexed

About

John I. Mackowiak is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, John I. Mackowiak has authored 48 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Pharmacology. Recurrent topics in John I. Mackowiak's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Inflammatory mediators and NSAID effects (3 papers). John I. Mackowiak is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Inflammatory mediators and NSAID effects (3 papers). John I. Mackowiak collaborates with scholars based in United States, Poland and Netherlands. John I. Mackowiak's co-authors include Donald A. Mahler, Henri R. Manasse, Clayton A. Peimer, Jean Paul Gagnon, Sue Ellen Cox, Bernard F. Cole, Jonathan W. Kowalski, Marc C. Chamberlain, Kurt A. Jaeckle and Chris M Kozma and has published in prestigious journals such as Cancer, CHEST Journal and Social Science & Medicine.

In The Last Decade

John I. Mackowiak

47 papers receiving 866 citations

Peers

John I. Mackowiak
Elizabeth H. Jones United Kingdom
Ming Teng United States
Susie Q. Lew United States
Per Ivarsen Denmark
Jameela A. Kari Saudi Arabia
Michael Suranyi Australia
Britt B. Newsome United States
Alferso C Abrahams Netherlands
Elizabeth H. Jones United Kingdom
John I. Mackowiak
Citations per year, relative to John I. Mackowiak John I. Mackowiak (= 1×) peers Elizabeth H. Jones

Countries citing papers authored by John I. Mackowiak

Since Specialization
Citations

This map shows the geographic impact of John I. Mackowiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John I. Mackowiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John I. Mackowiak more than expected).

Fields of papers citing papers by John I. Mackowiak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John I. Mackowiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John I. Mackowiak. The network helps show where John I. Mackowiak may publish in the future.

Co-authorship network of co-authors of John I. Mackowiak

This figure shows the co-authorship network connecting the top 25 collaborators of John I. Mackowiak. A scholar is included among the top collaborators of John I. Mackowiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John I. Mackowiak. John I. Mackowiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Adams, Kirkwood F., Javed Butler, J. Herbert Patterson, et al.. (2016). Dose Response Characterization of the Association of Serum Digoxin Concentration with Mortality Outcomes in the Digitalis Investigation Group Trial. European Journal of Heart Failure. 18(8). 1072–1081. 38 indexed citations
3.
Adams, Kirkwood F., Jalal K. Ghali, J. Herbert Patterson, et al.. (2014). A Perspective on Re-Evaluating Digoxin's Role in the Current Management of Patients with Chronic Systolic Heart Failure: Targeting Serum Concentration to Reduce Hospitalization and Improve Safety Profile. European Journal of Heart Failure. 16(5). 483–493. 18 indexed citations
4.
Peimer, Clayton A., et al.. (2013). Collagenase Clostridium Histolyticum for Dupuytren Contracture: Patterns of Use and Effectiveness in Clinical Practice. The Journal Of Hand Surgery. 38(12). 2370–2376. 38 indexed citations
5.
Vo, Ashley, Jeffrey J. Petrozzino, Kai Tai Derek Yeung, et al.. (2013). Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab. Transplantation. 95(6). 852–858. 82 indexed citations
6.
Kozma, Chris M, et al.. (2011). Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study. BMC Pulmonary Medicine. 11(1). 61–61. 12 indexed citations
7.
Mackowiak, John I., et al.. (2011). PMS4 Efficacy and Effectiveness of Collagenase Clostridium Histolyticum for Dupuytren'S Contracture. Value in Health. 14(7). A302–A302. 2 indexed citations
8.
Hammond, Jeff R., Chris M Kozma, James Hart, et al.. (2011). Rates of Venous Thromboembolism Among Patients with Major Surgery for Cancer. Annals of Surgical Oncology. 18(12). 3240–3247. 30 indexed citations
9.
Kozma, Chris M, Michael Dickson, Monika Raut, et al.. (2010). Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP). Journal of Medical Economics. 13(4). 719–727. 29 indexed citations
10.
Adamski, Zbigniew, et al.. (2005). Fenitrothion-induced cell malformations in vitro in Spodoptera exigua cell line UCR-Se-1. 42(1). 5 indexed citations
11.
Mackowiak, John I., et al.. (2004). Triptan Therapy Impacts Health and Productivity. Journal of Occupational and Environmental Medicine. 46(8). 812–817. 14 indexed citations
12.
Cole, Bernard F., Michael Glantz, Kurt A. Jaeckle, Marc C. Chamberlain, & John I. Mackowiak. (2003). Quality‐of‐life–adjusted survival comparison of sustained‐release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis. Cancer. 97(12). 3053–3060. 55 indexed citations
13.
Wasserman, Todd H., et al.. (2000). Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer. International Journal of Radiation Oncology*Biology*Physics. 48(4). 1035–1039. 58 indexed citations
14.
Sclar, David A., et al.. (1997). Cost Benefit of Sumatriptan to an Employer. Journal of Occupational and Environmental Medicine. 39(7). 652–657. 33 indexed citations
15.
Segal, Richard, L. Douglas Ried, & John I. Mackowiak. (1995). Cost of asthma illnesses: emergency department visits without admission.. PubMed. 15(3). 72–82. 10 indexed citations
16.
Adamski, Zbigniew, et al.. (1995). Catalase and superoxide dismutase activity in Rana esculenta organs. 32. 1 indexed citations
17.
Mahler, Donald A. & John I. Mackowiak. (1995). Evaluation of the Short-Form 36-Item Questionnaire to Measure Health-Related Quality of Life in Patients With COPD. CHEST Journal. 107(6). 1585–1589. 252 indexed citations
18.
Mackowiak, John I., et al.. (1992). The effect of collagen degradation products (CDP) on the central nervous system (CNS).. PubMed. 37. 8–17. 2 indexed citations
19.
Mackowiak, John I., et al.. (1977). Influence of globulin degradation products (GDP) on some centrally acting drugs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(2). 113–21. 1 indexed citations
20.
Mackowiak, John I.. (1966). Physical chemistry for metallurgists. Medical Entomology and Zoology. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026